Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Seed CoTSE:7743 64 EV-to-EBIT is 31.61 as of Sep. 02, 2026, which is 27% above its 10-year median of 24.92. GuruFocus rates TSE:7743 with a GF Score™ of 64/100 and a GF Value™ of 円539.40 (Significantly Overvalued). The stock has 9 warning signs investors should review. Among 474 Medical Devices & Instruments companies, Seed Co ranks worse than 72.15% on this metric.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Seed Co's Enterprise Value is 円57,684 Mil.
Seed Co's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 was 円1,825 Mil. Therefore, Seed Co's EV-to-EBIT for today is 31.61.
The historical rank and industry rank for Seed Co's EV-to-EBIT or its related term are showing as below:
TSE:7743'
s EV-to-EBIT Range Over the Past 10 Years
Min: 13.77 Med: 24.92 Max: 255.17
Current: 31.61
During the past 13 years, the highest EV-to-EBIT of Seed Co was 255.17. The lowest was 13.77. And the median was 24.92.
TSE:7743's EV-to-EBIT is ranked worse than 72.15% of 474
companies
in the Medical Devices & Instruments industry
Industry Median: 18.7
vs TSE:7743: 31.61
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Seed Co's Enterprise Value for the quarter that ended in Jun. 2026 was 円49,209 Mil.
Seed Co's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円1,825 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Seed Co EV-to-EBIT Related Terms
Seed Co EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Seed Co's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Seed Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Seed Co EV-to-EBIT vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Seed Co's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Seed Co's EV-to-EBIT falls into.
Seed Co's current Enterprise Value is 円57,684 Mil.
Seed Co's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円1,825 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Seed Co (TSE:7743) has a EV-to-EBIT of 31.61 as of Sep. 02, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Seed Co and its competitors. This is 27% above median its historical median of 24.92. Over the past decade, Seed Co's EV-to-EBIT has ranged from 13.77 to 255.17. According to the industry distribution chart, Seed Co ranks #342 out of 474 companies in the Medical Devices & Instruments industry, placing it in the top 72.2%.
Is Seed Co's EV-to-EBIT too high?
Seed Co's current EV-to-EBIT of 31.61 is 27% above median its 10-year median of 24.92. Over the past 10 years, this metric has ranged from a low of 13.77 to a high of 255.17. The Medical Devices & Instruments industry median EV-to-EBIT is 18.70. Seed Co's value of 31.61 is 69% above this industry median. Based on the distribution chart, Seed Co ranks #342 out of 474 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Seed Co has a GF Score™ of 64/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Seed Co's EV-to-EBIT compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Seed Co ranks #342 out of 474 companies for EV-to-EBIT. This places Seed Co in the lower half of its industry. The industry median EV-to-EBIT is 18.70. Seed Co's value of 31.61 is 69% above this benchmark. Historically, Seed Co's own EV-to-EBIT has ranged from 13.77 to 255.17 over the past decade. While the company's 10-year median is 24.92 vs. the industry median of 18.70, Seed Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Devices & Instruments company?
The median EV-to-EBIT among Medical Devices & Instruments companies is 18.70, based on 474 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Seed Co's current EV-to-EBIT of 31.61 is 69% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Seed Co and its competitors. For the Medical Devices & Instruments industry, the median EV-to-EBIT is 18.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Seed Co's current EV-to-EBIT is 31.61, which is 27% above median its own 10-year median of 24.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Seed Co stock overvalued right now?
Based on GuruFocus' analysis, Seed Co (TSE:7743) is currently considered Significantly Overvalued. The stock's GF Value™ is 円539.40, compared to a current price of 円792.00 — trading 46.8% above its estimated fair value. The current EV-to-EBIT is 31.61, which is 27% above median its 10-year median of 24.92 and 69% above the Medical Devices & Instruments industry median of 18.70. Seed Co's overall GF Score™ is 64/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Seed Co (TSE:7743), the current EV-to-EBIT is 31.61 as of Sep. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Seed Co (TSE:7743) Overvalued in 2026?
Based on GuruFocus' analysis, Seed Co stock appears to be overvalued.
The current stock price of 円792.00 is trading 46.8% above its estimated GF Value™ of 円539.40.
GuruFocus considers Seed Co to be Significantly Overvalued.
Key valuation signals for TSE:7743:
EV-to-EBIT: 31.61 (27% above median its 10-year median of 24.92)
GF Value™: 円539.40 vs. price of 円792.00 (46.8% above fair value)
Industry Position: 69% above the Medical Devices & Instruments median (#342 of 474)
No single metric tells the full story. See the TSE:7743 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Seed Co Ltd is engaged in the manufacturing and sells of contact lenses, glasses frames, and other eye care products in Japan. Its main products include SEED 1dayPure daily disposable lenses, SEED Fine disposable lenses, SEED S-1 high oxygen permeability hard contact lenses.
64GF Score
Get the complete analysis for TSE:7743
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7743 has been successfully added to your 
